| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75e50d733fb6b306dcb2ede1a636a54f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
| filingDate |
2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7862d23bd18fb88fa23aed60f3fe386 |
| publicationDate |
2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017004567-A1 |
| titleOfInvention |
Compositions and methods for combination therapy with dengue virus and dendritic cells |
| abstract |
Described herein are compositions and methods for treating cancer through the combination of tumor antigen-pulsed dendritic cells and Dengue Virus. The combination of the two forms of therapeutic intervention provides enhanced cancer cell reduction compared to either alone. The cancer targeted by compositions and methods described herein may be a solid cancer or blood cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3541417-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110996997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9730989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3865150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018232166-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9849167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357553-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110139671-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675304-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946080-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020527540-A |
| priorityDate |
2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |